Mark S Nestor1,2,3,4,5,6,7, Brian Berman1,2,3,4,5,6,7, David Goldberg1,2,3,4,5,6,7, Armand B Cognetta1,2,3,4,5,6,7, Michael Gold1,2,3,4,5,6,7, William Roth1,2,3,4,5,6,7, Clay J Cockerell1,2,3,4,5,6,7, Brad Glick1,2,3,4,5,6,7. 1. Drs. Nestor and Berman are with the Center for Clinical and Cosmetic Research in A ventura, Florida and the Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine in Miami, Florida. 2. Dr. Goldberg is with Skin Laser & Surgery Specialists of NY/NJ, Icahn School of Medicine at Mount Sinai, and Fordham Law School in New York, New York. 3. Dr. Cognetta is with Dermatology Associates of Tallahassee in Tallahassee, Florida. 4. Dr. Gold is with Gold Skin Care Center, the Tennessee Clinical Research Center, Vanderbilt University School of Nursing, and Meharry Medical College School of Medicine in Nashville, Tennessee. 5. Dr. Roth is with Dermatology and Dermatological Surgery in Boynton Beach, Florida. 6. Dr. Cockerell is with Cockerell Dermatopathology in Dallas, Texas. 7. Dr. Glick is with the Glick Skin Institute in Margate, Florida.
Abstract
Background: The use of superficial radiation therapy (SRT) has experienced a renaissance for treating nonmelanoma skin cancers (NMSCs) and recurrent keloids; however, published treatment guidelines are lacking. Objective: The objective of this work was to provide consensus guidelines on the use of SRT for treating NMSC and recurrent keloids based on a review of the literature and expert opinion. Methods and Materials: A search of the medical literature was performed to obtain published information on the use of SRT for review. A group of qualified dermatologists convened to discuss their views on the use of SRT for the treatment of NMSCs and recurrent keloids. The various guidelines were considered to have consensus based on a supermajority two-thirds vote. The final consensus guidelines are thus based on the medical literature, when available, and expert opinions. Results: Agreement on consensus guidelines was reached for numerous aspects of SRT use, including appropriate tumor types for SRT; anatomical areas suitable for SRT; energy, fractions, and scheduling recommendations for SRT; use of SRT in the presence of comorbidities; safety factors; and treatment recommendations for recurrent keloids, based the literature and on both the opinions of the expert group and a survey of experienced users. Conclusion: Consensus was reached that SRT is a safe and effective treatment for basal cell and squamous cell carcinomas and should be considered as the first-line form of radiation treatment. Postsurgical treatment of keloid excision suture lines with SRT significantly reduces keloid recurrence rates.
Background: The use of superficial radiation therapy (SRT) has experienced a renaissance for treating nonmelanoma skin cancers (NMSCs) and recurrent keloids; however, published treatment guidelines are lacking. Objective: The objective of this work was to provide consensus guidelines on the use of SRT for treating NMSC and recurrent keloids based on a review of the literature and expert opinion. Methods and Materials: A search of the medical literature was performed to obtain published information on the use of SRT for review. A group of qualified dermatologists convened to discuss their views on the use of SRT for the treatment of NMSCs and recurrent keloids. The various guidelines were considered to have consensus based on a supermajority two-thirds vote. The final consensus guidelines are thus based on the medical literature, when available, and expert opinions. Results: Agreement on consensus guidelines was reached for numerous aspects of SRT use, including appropriate tumor types for SRT; anatomical areas suitable for SRT; energy, fractions, and scheduling recommendations for SRT; use of SRT in the presence of comorbidities; safety factors; and treatment recommendations for recurrent keloids, based the literature and on both the opinions of the expert group and a survey of experienced users. Conclusion: Consensus was reached that SRT is a safe and effective treatment for basal cell and squamous cell carcinomas and should be considered as the first-line form of radiation treatment. Postsurgical treatment of keloid excision suture lines with SRT significantly reduces keloid recurrence rates.
Entities:
Keywords:
Superficial radiation therapy; consensus guidelines; literature review; nonmelanoma skin cancer
Authors: N Mitsuhashi; K Hayakawa; M Yamakawa; H Sakurai; Y Saito; M Hasegawa; T Akimoto; K Hayakawa; H Niibe Journal: Radiology Date: 1999-06 Impact factor: 11.105
Authors: May N Tsao; Richard W Tsang; Fei Fei Liu; Tony Panzarella; Lorne Rotstein Journal: Int J Radiat Oncol Biol Phys Date: 2002-03-15 Impact factor: 7.038
Authors: William R Bodner; Basil S Hilaris; Mehran Alagheband; Bijan Safai; Constance A Mastoras; Sharad Saraf Journal: Cancer Invest Date: 2003-06 Impact factor: 2.176
Authors: Brian Berman; Mark S Nestor; Michael H Gold; David J Goldberg; Eduardo T Weiss; Isabelle Raymond Journal: J Clin Aesthet Dermatol Date: 2020-10-01